Your browser doesn't support javascript.
loading
Application of the model-informed drug development paradigm to datopotamab deruxtecan dose selection for late-stage development.
Lu, Yasong; Liang, Shuang; Hong, Ying; Tajima, Naoyuki; Patel, Kashyap; Li, Hanbin; Wada, David R; Greenberg, Jon; Petrich, Adam; Zebger-Gong, Hong; Shuster, Dale; Vaddady, Pavan.
Afiliação
  • Lu Y; Quantitative Clinical Pharmacology, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.
  • Liang S; Quantitative Clinical Pharmacology, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.
  • Hong Y; Quantitative Clinical Pharmacology, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.
  • Tajima N; Quantitative Clinical Pharmacology, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.
  • Patel K; Certara Strategic Consulting, Princeton, New Jersey, USA.
  • Li H; QuanTx Consulting, Mountain View, California, USA.
  • Wada DR; QuanTx Consulting, Mountain View, California, USA.
  • Greenberg J; Global Oncology R&D, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.
  • Petrich A; Global Oncology R&D, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.
  • Zebger-Gong H; Global Oncology Clinical Development, Daiichi Sankyo Europe GmbH, Munich, Germany.
  • Shuster D; Global Oncology R&D, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.
  • Vaddady P; Quantitative Clinical Pharmacology, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.
CPT Pharmacometrics Syst Pharmacol ; 13(1): 23-28, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37915242

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Imunoconjugados / Neoplasias Pulmonares / Antineoplásicos Limite: Humans Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Imunoconjugados / Neoplasias Pulmonares / Antineoplásicos Limite: Humans Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Ano de publicação: 2024 Tipo de documento: Article